Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MIF | P14174 | 5/20 | 0.49 |
| ▸ | MAOB | P27338 | 6/20 | 0.47 |
| ▸ | MAOA | P21397 | 5/20 | 0.47 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.46 |
| ▸ | CYP26A1 | O43174 | 1/20 | 0.39 |
| ▸ | ABAT | P80404 | 1/20 | 0.38 |
| ▸ | DYRK1A | Q13627 | 2/20 | 0.37 |
| ▸ | DYRK2 | Q92630 | 2/20 | 0.37 |
| ▸ | DYRK1B | Q9Y463 | 2/20 | 0.37 |
| ▸ | TYR | P14679 | 1/20 | 0.37 |
| ▸ | ESR1 | P03372 | 1/20 | 0.36 |
| ▸ | ESR2 | Q92731 | 1/20 | 0.36 |
| ▸ | APP | P05067 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL22046626 | 0.74 | MAOB (0.48) | MIFMAOBMAOAKMT2AABAT | |
| SCHEMBL22046148 | 0.69 | MAOB (0.43) | MAOBMAOAKMT2ATYR | |
| SCHEMBL29837280 | 0.66 | MIF (1.00) | MIFMAOBMAOAKMT2ACYP26A1 | |
| SCHEMBL30251430 | 0.65 | MAOB (1.00) | MAOBMAOAESR2 | |
| SCHEMBL1091999 | 0.65 | MAOB (1.00) | MAOBMAOAESR2 | |
| SCHEMBL26777072 | 0.65 | MAOA (0.64) | MIFMAOBMAOACYP26A1ESR1 | |
| Water SCHEMBL15676351 | 0.64 | MAOB (0.96) | MAOBMAOAESR2 | |
| SCHEMBL6143494 | 0.64 | ALDH1A1 (0.61) | MIFMAOBMAOAKMT2ADYRK1A | |
| SCHEMBL9490046 | 0.64 | KMT2A (1.00) | MIFMAOBKMT2ADYRK1ADYRK2 | |
| SCHEMBL6142893 | 0.64 | ALDH1A1 (0.61) | MIFMAOBMAOAKMT2ADYRK1A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11821901-B2 | Styryl phenols, derivatives and their use in methods of analyte detection | AAT BIOQUEST, INC. (US) | 2023-11-21 | — | — | US | disclosed |
| US-11821901-B2 | Styryl phenols, derivatives and their use in methods of analyte detection | AAT BIOQUEST, INC. (US) | 2023-11-21 | — | — | US | disclosed |
| US-11237170-B2 | Styryl phenols, derivatives and their use in methods of analyte detection | AAT BIOQUEST, INC. (US) | 2022-02-01 | — | — | US | disclosed |
| US-20200378975-A1 | STYRYL PHENOLS, DERIVATIVES AND THEIR USE IN METHODS OF ANALYTE DETECTION | AAT BIOQUEST, INC. (US) | 2020-12-03 | — | — | US | disclosed |
| US-20200174006-A1 | Styryl phenols, derivatives and their use in methods of analyte detection | AAT BIOQUEST, INC. | 2020-06-04 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11821901-B2 | Styryl phenols, derivatives and their use in methods of analyte detection | STUB1, SPR, HLCS | MIF 3403/4885MAOB 272/4885MAOA 1625/4885 |
| US-20200174006-A1 | Styryl phenols, derivatives and their use in methods of analyte detection | STUB1, SPR, HLCS | MIF 3403/4885MAOB 272/4885MAOA 1625/4885 |
| US-11237170-B2 | Styryl phenols, derivatives and their use in methods of analyte detection | STUB1, SPR, HLCS | MIF 3403/4885MAOB 272/4885MAOA 1625/4885 |
| US-20200378975-A1 | STYRYL PHENOLS, DERIVATIVES AND THEIR USE IN METHODS OF ANALYTE DETECTION | STUB1, SPR, HLCS | MIF 3403/4885MAOB 272/4885MAOA 1625/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.